| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Jun 3, 2019Virtual Press Office and PR Newswire: General Trade show news
McIvor will present "Designing Technology for Caregivers" at d.health's "Transforming the Way We Care" pre-summit on Monday, June 10th in Cambridge, Massachusetts. McIvor will discuss critical...
-
Jun 3, 2019Virtual Press Office and PR Newswire: General Trade show news
ASMS 2019 – Scientists in academic, government and biopharmaceutical laboratories who are faced with increasingly complex research challenges now have access to a digitally advanced Thermo...
-
Jun 3, 2019Virtual Press Office and PR Newswire: General Trade show news
NeuroRX, a clinical-stage biopharma company developing the first oral therapy for Severe Bipolar Depression with Acute Suicidal Ideation or Behavior, will present phase 2 efficacy results from its...
-
Jun 3, 2019Virtual Press Office and PR Newswire: General Trade show news
As a not-for-profit serving the defense and intelligence communities, Riverside Research is excited to exhibit in this year's 2019 Geospatial Intelligence (GEOINT) Symposium and present two...
-
Jun 3, 2019Virtual Press Office and PR Newswire: General Trade show news
Vectrus, Inc. (NYSE: VEC), announced that company management will address the Stifel 2019 Cross Sector Insight Conference in Boston on Wednesday, June 12, at 9:45 a.m. Eastern time, and meet with...
-
Jun 3, 2019Virtual Press Office and PR Newswire: General Trade show news
Astellas Pharma Inc. (TSE: 4503) (President and CEO: Kenji Yasukawa, Ph.D., "Astellas") and Seattle Genetics, Inc. (Nasdaq: SGEN) today announced that data from the first cohort of a pivotal phase...
-
Jun 3, 2019Virtual Press Office and PR Newswire: General Trade show news
CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its CytoSorb® blood purification technology to treat deadly inflammation in critically-ill and...
-
Jun 3, 2019Virtual Press Office and PR Newswire: General Trade show news
Proteostasis Therapeutics, Inc. (NASDAQ: PTI), a clinical stage biopharmaceutical company dedicated to the discovery and development of groundbreaking therapies to treat cystic fibrosis (CF) and...
-
Jun 3, 2019Virtual Press Office and PR Newswire: General Trade show news
Fiber Connect 2019, Booth 1401 -- OFS is pleased to introduce Fortex 2DT Loose Tube Fiber Optic Cable, the newest addition to the company's Fortex DT completely gel-free cable portfolio. Fortex...
-
Jun 3, 2019Virtual Press Office and PR Newswire: General Trade show news
Fiber Connect 2019, Booth 1401 - OFS, a leading manufacturer of innovative fiber optic products, today introduces the EZ-Terminator to its portfolio of FITEL Connectivity Solutions. A key tool for...
